loading...| Preferred Name | methyldopa | |
| Synonyms |
alphamethyldopa alpha-methyl-L-dopa α-methyldopa alpha medopa |
|
| Definitions |
This is any condition in which the main influencing factor is methyldopa, a centrally acting sympatholytic agent and an antihypertensive agent. It is an analog of DOPA (3,4‐hydroxyphenylanine), and it is a prodrug, meaning that the drug requires biotransformation to an active metabolite for therapeutic effects. Methyldopa is in the alpha-2 adrenergic receptor agonist family of medications. It works by stimulating the brain to decrease the activity of the sympathetic nervous system. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001182 |
|
| created_by |
slaulederkind |
|
| creation_date |
2023-12-12T13:26:35Z |
|
| database_cross_reference |
MESH:D008750 |
|
| definition |
This is any condition in which the main influencing factor is methyldopa, a centrally acting sympatholytic agent and an antihypertensive agent. It is an analog of DOPA (3,4‐hydroxyphenylanine), and it is a prodrug, meaning that the drug requires biotransformation to an active metabolite for therapeutic effects. Methyldopa is in the alpha-2 adrenergic receptor agonist family of medications. It works by stimulating the brain to decrease the activity of the sympathetic nervous system. |
|
| has_exact_synonym |
alphamethyldopa alpha-methyl-L-dopa α-methyldopa alpha medopa |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0001182 |
|
| label |
methyldopa |
|
| notation |
XCO:0001182 |
|
| prefLabel |
methyldopa |
|
| treeView | ||
| subClassOf |